Derek A DuBay1, David T Redden, Mary K Bryant, David P Dorn, Mona N Fouad, Stephen H Gray, Jared A White, Jayme E Locke, Christopher B Meeks, Garry C Taylor, Meredith L Kilgore, Devin E Eckhoff. 1. 1 Division of Abdominal Transplant, University of Alabama at Birmingham, Birmingham, AL. 2 School of Public Health-Biostatistics, University of Alabama at Birmingham Birmingham, AL. 3 Preventive Medicine, University of Alabama at Birmingham Birmingham, AL. 4 Alabama Organ Center, Health Services Foundation, Birmingham, Alabama. 5 School of Public Health-Health Care Organization and Policy, University of Alabama at Birmingham Birmingham, AL. 6 Address correspondence to: Derek A. DuBay, M.D., Division of Transplantation University of Alabama at Birmingham ZRB 701, 1530 3rd Ave, S Birmingham, AL 35294-0007.
Abstract
BACKGROUND: The strategy of evaluating every donation opportunity warrants an investigation into the financial feasibility of this practice. The purpose of this investigation is to measure resource utilization required for procurement of transplantable organs in an organ procurement organization (OPO). METHODS: Donors were stratified into those that met OPTN-defined eligible death criteria (ED donors, n=589) and those that did not (NED donors, n=703). Variable direct costs and time utilization by OPO staff for organ procurement were measured and amortized per organ transplanted using permutation methods and statistical bootstrapping/resampling approaches. RESULTS: More organs per donor were procured (3.66±1.2 vs. 2.34±0.8, P<0.0001) and transplanted (3.51±1.2 vs. 2.08±0.8, P<0.0001) in ED donors compared with NED donors. The variable direct costs were significantly lower in the NED donors ($29,879.4±11590.1 vs. $19,019.6±7599.60, P<0.0001). In contrast, the amortized variable direct costs per organ transplanted were significantly higher in the NED donors ($8,414.5±138.29 vs. $9,272.04±344.56, P<0.0001). The ED donors where thoracic organ procurement occurred were 67% more expensive than in abdominal-only organ procurement. The total time allocated per donor was significantly shorter in the NED donors (91.2±44.9 hr vs. 86.8±78.6 hr, P=0.01). In contrast, the amortized time per organ transplanted was significantly longer in the NED donors (23.1±0.8 hr vs. 36.9±3.2 hr, P<0.001). DISCUSSION: The variable direct costs and time allocated per organ transplanted is significantly higher in donors that do not meet the eligible death criteria.
BACKGROUND: The strategy of evaluating every donation opportunity warrants an investigation into the financial feasibility of this practice. The purpose of this investigation is to measure resource utilization required for procurement of transplantable organs in an organ procurement organization (OPO). METHODS: Donors were stratified into those that met OPTN-defined eligible death criteria (ED donors, n=589) and those that did not (NED donors, n=703). Variable direct costs and time utilization by OPO staff for organ procurement were measured and amortized per organ transplanted using permutation methods and statistical bootstrapping/resampling approaches. RESULTS: More organs per donor were procured (3.66±1.2 vs. 2.34±0.8, P<0.0001) and transplanted (3.51±1.2 vs. 2.08±0.8, P<0.0001) in ED donors compared with NED donors. The variable direct costs were significantly lower in the NED donors ($29,879.4±11590.1 vs. $19,019.6±7599.60, P<0.0001). In contrast, the amortized variable direct costs per organ transplanted were significantly higher in the NED donors ($8,414.5±138.29 vs. $9,272.04±344.56, P<0.0001). The ED donors where thoracic organ procurement occurred were 67% more expensive than in abdominal-only organ procurement. The total time allocated per donor was significantly shorter in the NED donors (91.2±44.9 hr vs. 86.8±78.6 hr, P=0.01). In contrast, the amortized time per organ transplanted was significantly longer in the NED donors (23.1±0.8 hr vs. 36.9±3.2 hr, P<0.001). DISCUSSION: The variable direct costs and time allocated per organ transplanted is significantly higher in donors that do not meet the eligible death criteria.
Authors: W H Marks; D Wagner; T C Pearson; J P Orlowski; P W Nelson; J J McGowan; M K Guidinger; J Burdick Journal: Am J Transplant Date: 2006 Impact factor: 8.086
Authors: Colleen L Jay; Vadim Lyuksemburg; Raymond Kang; Luke Preczewski; Kevin Stroupe; Jane L Holl; Michael M Abecassis; Anton I Skaro Journal: Ann Surg Date: 2010-04 Impact factor: 12.969
Authors: M J Englesbe; Y Ads; J A Cohn; C J Sonnenday; R Lynch; R S Sung; S J Pelletier; J D Birkmeyer; J D Punch Journal: Am J Transplant Date: 2008-03 Impact factor: 8.086
Authors: D A DuBay; P A MacLennan; R D Reed; M Fouad; M Martin; C B Meeks; G Taylor; M L Kilgore; M Tankersley; S H Gray; J A White; D E Eckhoff; J E Locke Journal: Am J Transplant Date: 2015-02 Impact factor: 8.086